SLC34A1

Sodium-dependent phosphate transport protein 2A · Q06495 · SLC34A1 on Sugi Atlas →

10,091 patent compounds predicted against SLC34A1, 3,991 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL610120	0.41	8/20
SCHEMBL378335	0.57	6/20
SCHEMBL183257	0.41	5/20
SCHEMBL123446	0.49	4/20
SCHEMBL391590	0.42	2/20
SCHEMBL415627	0.34	2/20
SCHEMBL267024	1.00	1/20
SCHEMBL267025	1.00	1/20
Phosphoric Acid (SCHEMBL134996)	0.90	1/20
Phosphoric Acid (SCHEMBL532270)	0.82	1/20
Phosphoric Acid (SCHEMBL74378)	0.80	1/20
Phosphoric Acid (SCHEMBL134059)	0.80	1/20
Phosphoric Acid (SCHEMBL184098)	0.80	1/20
Phosphoric Acid (SCHEMBL186335)	0.80	1/20
Phosphoric Acid (SCHEMBL248632)	0.80	1/20
Phosphoric Acid (SCHEMBL295914)	0.80	1/20
Phosphoric Acid (SCHEMBL307086)	0.80	1/20
Phosphoric Acid (SCHEMBL319774)	0.80	1/20
Phosphoric Acid (SCHEMBL515130)	0.80	1/20
Phosphoric Acid (SCHEMBL515615)	0.80	1/20

Clinical trials — most relevant to SLC34A1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effect of Age on the Renal Clearance of Adefovir	PHASE4	WITHDRAWN
Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH	PHASE3	COMPLETED
BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases	PHASE2/PHASE3	WITHDRAWN
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)	PHASE2	COMPLETED
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	PHASE1/PHASE2	COMPLETED
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®	PHASE1/PHASE2	COMPLETED
Healthy Combine Study	PHASE1	COMPLETED
Effect of, OAT3, on the Renal Secretion of Cefotaxime	PHASE1	COMPLETED
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors	PHASE1	COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters	EARLY_PHASE1	COMPLETED
Oxalate and Citrate in Humans - Response to Citrate	nan	RECRUITING
Cardiovascular Effects of Empagliflozine	nan	UNKNOWN
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals	nan	ENROLLING_BY_INVITATION
Calcitonin for Treating X-linked Hypophosphatemia	nan	COMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy	nan	COMPLETED
Sodium Transport: Genetics and Hypertension	nan	COMPLETED
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital	nan	UNKNOWN
The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia	nan	COMPLETED
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS	nan	NOT_YET_RECRUITING
Oxalate and Citrate	nan	RECRUITING
Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism	nan	NOT_YET_RECRUITING
Epidemiology of Gout in French Polynesia	nan	COMPLETED
Biological Collection of Kidney Cells	nan	UNKNOWN
Studying Phosphorus Metabolism	nan	COMPLETED
Lithium Countertransport and Blood Pressure In CARDIA and TOMHS	nan	COMPLETED
Secondary Sclerosing Cholangitis in Critically Ill Patients	nan	ACTIVE_NOT_RECRUITING
Renal Transporters After Renal Transplantation	nan	UNKNOWN
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management	nan	UNKNOWN
Characterization of Breg Cells	nan	COMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC34A1 binder may also engage these)

Protein	Name	Similarity
O97704	—	1.000	O97704 →
Q28620	—	1.000	Q28620 →
Q60825	—	0.999	Q60825 →
Q80SU6	—	0.998	Q80SU6 →
Q06496	—	0.996	Q06496 →
Q8K4R8	—	0.993	Q8K4R8 →
SLC34A3	Sodium-dependent phosphate transport protein 2C	0.992	landscape →
Q9DBP0	—	0.986	Q9DBP0 →
Q9JJ09	—	0.983	Q9JJ09 →
Q5REV9	—	0.981	Q5REV9 →
Q27960	—	0.977	Q27960 →
Q64347	—	0.975	Q64347 →
SLC34A2	Sodium-dependent phosphate transport protein 2B	0.975	landscape →
P35524	—	0.972	P35524 →
A1A4I1	—	0.972	A1A4I1 →
D2HSA6	—	0.971	D2HSA6 →
Q8IUH8	—	0.971	Q8IUH8 →
P35523	—	0.971	P35523 →
SOAT2	Sterol O-acyltransferase 2	0.971	landscape →
Q96Q91	—	0.971	Q96Q91 →
Q5E9R1	—	0.971	Q5E9R1 →
Q6PFM1	—	0.970	Q6PFM1 →
Q9NQ40	—	0.970	Q9NQ40 →
Q8K4V2	—	0.970	Q8K4V2 →
A2A6C4	—	0.970	A2A6C4 →
SLC5A11	Sodium/myo-inositol cotransporter 2	0.970	landscape →
Q4FZU9	—	0.970	Q4FZU9 →
A1A4N1	—	0.969	A1A4N1 →
Q28E01	—	0.969	Q28E01 →
O88908	—	0.968	O88908 →